ANIK vs IQV · rev $62.2M vs P/E 23, rev $16.31B
Anika Therapeutics Inc (ANIK) versus IQVIA Holdings Inc (IQV) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
ANIK currently screens at market cap $161.3M. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Not investment advice. Open the ANIK and IQV stock pages for the full models.
Not investment advice.